Repealing the Collaborative Care Pilot Program; and requiring the Maryland Department of Health to expand access to and provide reimbursement for services provided in accordance with the Collaborative Care Model under the Maryland Medical Assistance Program.
Establishing the Commission on Universal Health Care to develop a plan for the State, by July 1, 2026, to establish a universal health care program to provide health benefits to all residents of the State through a single-payer system; requiring a member of the Commission to be subject to ethics laws and disclose certain other information related to ethics; and prohibiting a member of the Commission from being held personally liable for actions taken as a member under certain circumstances.
Requiring the Maryland Health Benefit Exchange and the Maryland Department of Health to develop a report comparing options for offering affordable health care and dental care coverage to State residents who are ineligible for the Maryland Medical Assistance Program, the Maryland Children's Health Program, qualified health plans, or stand-alone dental plans due to the individuals' immigration status; and requiring the Maryland Health Benefit Exchange to report its findings and recommendations by October 31, 2023.
Requiring the Maryland Health Benefit Exchange and the Maryland Department of Health to develop a report comparing options for offering affordable health care and dental care coverage to State residents who are ineligible for the Maryland Medical Assistance Program, the Maryland Children's Health Program, qualified health plans, or stand-alone dental plans due to the individuals' immigration status; and requiring the Maryland Health Benefit Exchange to report its findings and recommendations by October 31, 2023.
Reestablishing the requirement that the Prescription Drug Affordability Board, under certain circumstances, draft a plan of action for implementing a process to set upper payment limits for certain prescription drug products; reestablishing the authority of the Board to set upper payments limits, under certain circumstances, for prescription drug products that are purchased or paid for by or through certain State or local government entities, plans, or programs; etc.
Reestablishing the requirement that the Prescription Drug Affordability Board, under certain circumstances, draft a plan of action for implementing a process to set upper payment limits for certain prescription drug products; reestablishing the authority of the Board to set upper payments limits, under certain circumstances, for prescription drug products that are purchased or paid for by or through certain State or local government entities, plans, or programs; etc.
Altering and establishing requirements and prohibitions related to health insurance utilization review, including provisions regarding benchmarks for standardizing and automating the preauthorization process, the online preauthorization system for payors, preauthorizations for prescription drugs, and private review agents; altering timelines related to internal grievance procedures and adverse decision procedures; increasing the penalties for violating certain provisions of law regarding private review agents; etc
Altering and establishing requirements and prohibitions related to health insurance utilization review, including provisions regarding benchmarks for standardizing and automating the preauthorization process, the online preauthorization system for payors, preauthorizations for prescription drugs, and private review agents; altering timelines related to internal grievance procedures and adverse decision procedures; increasing the penalties for violating certain provisions of law regarding private review agents; etc
Requiring the Secretary of Health to adopt regulations for pharmacy benefits managers that contract with managed care organizations that establish requirements for conducting audits of pharmacies or pharmacists; establishing requirements and prohibitions regarding audits by certain pharmacy benefits managers, including provisions related to audit limits, acceptance of certain documents as proof, recoupment of funds or charging of fees for prescriptions of unbreakable package sizes, and access to financial documentation; etc.
Requiring the Secretary of Health to adopt regulations for pharmacy benefits managers that contract with managed care organizations that establish requirements for conducting audits of pharmacies or pharmacists; establishing requirements and prohibitions regarding audits by certain pharmacy benefits managers, including provisions related to audit limits, acceptance of certain documents as proof, recoupment of funds or charging of fees for prescriptions of unbreakable package sizes, and access to financial documentation; etc.
